| pubmed-article:1795462 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1795462 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:1795462 | lifeskim:mentions | umls-concept:C0002962 | lld:lifeskim |
| pubmed-article:1795462 | lifeskim:mentions | umls-concept:C1705480 | lld:lifeskim |
| pubmed-article:1795462 | lifeskim:mentions | umls-concept:C0016017 | lld:lifeskim |
| pubmed-article:1795462 | lifeskim:mentions | umls-concept:C0205227 | lld:lifeskim |
| pubmed-article:1795462 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:1795462 | pubmed:dateCreated | 1992-4-9 | lld:pubmed |
| pubmed-article:1795462 | pubmed:abstractText | A relationship was examined between blood vasopressin levels and the fibrinolytic system in 35 patients with angina pectoris (16 with vasospastic angina (VA) and 19 with exercise-induced angina) who had undergone vein occlusion testing. There was a positive correlation between the post-testing vasopressin levels and the activity of tissue plasminogen activator inhibitor (TPAI) (r = 0.54) which was more high in patients with VA (r = 0.61). Only did the patients with VA show a direct relationship between the vasopressin concentrations and the activity of tissue plasminogen activator (TPA) (r = 0.63), the concentration of fibrinogen-fibrin degradation products (FFDP) (r = 0.88). Thirteen patients having higher vasopressin levels (over 3.4 ng/ml) displayed a greater TPAI activity than did the patients with vasopressin levels of at least 3.4 ng/ml (26.2 +/- 4.9 and 15.0 +/- 1.42 IU/ml, respectively; p less than 0.05). There was a direct relationship between the vasopressin levels and the activity of TPA (r = 0.65), the concentration of FFDP (r = 0.78) in patients having a vasopressin level of above 3.4 ng/ml. The findings are in agreement with the concept that endogenous vasopressin is involved in the regulation of the blood fibrinolytic system. | lld:pubmed |
| pubmed-article:1795462 | pubmed:language | rus | lld:pubmed |
| pubmed-article:1795462 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1795462 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1795462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1795462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1795462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1795462 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1795462 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:1795462 | pubmed:issn | 0022-9040 | lld:pubmed |
| pubmed-article:1795462 | pubmed:author | pubmed-author:MasenkoV PVP | lld:pubmed |
| pubmed-article:1795462 | pubmed:author | pubmed-author:Gratsianski?N... | lld:pubmed |
| pubmed-article:1795462 | pubmed:author | pubmed-author:Dobrovol'ski... | lld:pubmed |
| pubmed-article:1795462 | pubmed:author | pubmed-author:PanchenkoE... | lld:pubmed |
| pubmed-article:1795462 | pubmed:author | pubmed-author:Zate?shchikov... | lld:pubmed |
| pubmed-article:1795462 | pubmed:author | pubmed-author:AverkovO VOV | lld:pubmed |
| pubmed-article:1795462 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1795462 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:1795462 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1795462 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1795462 | pubmed:pagination | 11-4 | lld:pubmed |
| pubmed-article:1795462 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1795462 | pubmed:meshHeading | pubmed-meshheading:1795462-... | lld:pubmed |
| pubmed-article:1795462 | pubmed:meshHeading | pubmed-meshheading:1795462-... | lld:pubmed |
| pubmed-article:1795462 | pubmed:meshHeading | pubmed-meshheading:1795462-... | lld:pubmed |
| pubmed-article:1795462 | pubmed:meshHeading | pubmed-meshheading:1795462-... | lld:pubmed |
| pubmed-article:1795462 | pubmed:meshHeading | pubmed-meshheading:1795462-... | lld:pubmed |
| pubmed-article:1795462 | pubmed:meshHeading | pubmed-meshheading:1795462-... | lld:pubmed |
| pubmed-article:1795462 | pubmed:meshHeading | pubmed-meshheading:1795462-... | lld:pubmed |
| pubmed-article:1795462 | pubmed:meshHeading | pubmed-meshheading:1795462-... | lld:pubmed |
| pubmed-article:1795462 | pubmed:meshHeading | pubmed-meshheading:1795462-... | lld:pubmed |
| pubmed-article:1795462 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1795462 | pubmed:articleTitle | [Endogenous vasopressin and fibrinolysis in patients with angina pectoris]. | lld:pubmed |
| pubmed-article:1795462 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1795462 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:1795462 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:1795462 | pubmed:publicationType | Case Reports | lld:pubmed |
